The aim of this study was to comprehensively characterise the distribution and clinical significance of TLR4 and MyD88 expression in a cohort of ovarian neoplasms, which includes all common histologic subtypes and represents the largest such series studied to date [20], [23], [24], [27], [28]. Here, MYD88 is linked to ovarian neoplasm.